DK112027B - Process for the preparation of basic tricyclic compounds or their salts, formamides or N-halogenamines. - Google Patents

Process for the preparation of basic tricyclic compounds or their salts, formamides or N-halogenamines.

Info

Publication number
DK112027B
DK112027B DK367964AA DK367964A DK112027B DK 112027 B DK112027 B DK 112027B DK 367964A A DK367964A A DK 367964AA DK 367964 A DK367964 A DK 367964A DK 112027 B DK112027 B DK 112027B
Authority
DK
Denmark
Prior art keywords
halogenamines
formamides
salts
preparation
tricyclic compounds
Prior art date
Application number
DK367964AA
Other languages
Danish (da)
Inventor
W Prichard
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of DK112027B publication Critical patent/DK112027B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/29—Saturated compounds containing keto groups bound to rings
    • C07C49/313—Saturated compounds containing keto groups bound to rings polycyclic
    • C07C49/323—Saturated compounds containing keto groups bound to rings polycyclic having keto groups bound to condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK367964AA 1963-07-24 1964-07-23 Process for the preparation of basic tricyclic compounds or their salts, formamides or N-halogenamines. DK112027B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29723363A 1963-07-24 1963-07-24
US376259A US3352912A (en) 1963-07-24 1964-06-18 Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes

Publications (1)

Publication Number Publication Date
DK112027B true DK112027B (en) 1968-11-04

Family

ID=26970055

Family Applications (3)

Application Number Title Priority Date Filing Date
DK367964AA DK112027B (en) 1963-07-24 1964-07-23 Process for the preparation of basic tricyclic compounds or their salts, formamides or N-halogenamines.
DK353365AA DK114199B (en) 1963-07-24 1965-07-09 Process for the preparation of basic tricyclic compounds or salts thereof.
DK353265AA DK114769B (en) 1963-07-24 1965-07-09 Process for the preparation of basic tricyclic compounds or salts thereof.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK353365AA DK114199B (en) 1963-07-24 1965-07-09 Process for the preparation of basic tricyclic compounds or salts thereof.
DK353265AA DK114769B (en) 1963-07-24 1965-07-09 Process for the preparation of basic tricyclic compounds or salts thereof.

Country Status (14)

Country Link
US (1) US3352912A (en)
AT (1) AT279581B (en)
BE (1) BE650919A (en)
BR (1) BR6460975D0 (en)
CH (2) CH479535A (en)
DE (3) DE1793207A1 (en)
DK (3) DK112027B (en)
ES (1) ES302369A1 (en)
FI (3) FI42322B (en)
FR (1) FR1572956A (en)
GB (1) GB1069563A (en)
IL (1) IL21753A (en)
NL (2) NL6408505A (en)
SE (3) SE330693B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449422A (en) * 1966-02-09 1969-06-10 Smithkline Corp Pentacycloundecane amines
DE1294371B (en) * 1966-12-21 1969-05-08 Penicillin Ges Dauelsberg & Co Process for the preparation of 1-aminoadamantane and its N-alkyl or N-cyclohexyl derivatives
US3489802A (en) * 1967-01-23 1970-01-13 Du Pont Preparation of alpha-methyl-1-adamantane-methylamine and alpha,4 - dimethyl - 1 - bicyclo(2,2,2)octane methylamine
NL6900004A (en) * 1969-01-02 1970-07-06
US3682922A (en) * 1969-01-16 1972-08-08 Searle & Co N-acyl-n-{8 (n{40 ,n{40 -disubstituted amino)-alkyl{9 -1-adamantylmethylamines
JPS4828903B1 (en) * 1969-07-19 1973-09-05
US3624086A (en) * 1969-11-10 1971-11-30 Searle & Co Adamantanecarboxamidoalkanoic acid amides
US3852339A (en) * 1970-06-15 1974-12-03 Squibb & Sons Inc Aminoalkoxyphenylurea derivatives
US3879400A (en) * 1973-11-16 1975-04-22 Upjohn Co 1-Lower alkyl-(1-adamantylmethyl)piperidines and process for their preparation
JPS5346950A (en) * 1976-10-12 1978-04-27 Kao Corp (54)1-acetylaminotricyclo(4,3,1,12,5)undecane and its preparation
US4351847A (en) * 1981-06-26 1982-09-28 Pennwalt Corporation Antiviral alpha, alpha-dialkyl adamantylethylamines
US4551552A (en) * 1984-05-23 1985-11-05 E. I. Du Pont De Nemours And Company Process for preparing rimantadine
US4751245A (en) * 1986-06-25 1988-06-14 E. R. Squibb & Sons, Inc. Antifungal derivatives of N-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
US5576355A (en) * 1993-06-04 1996-11-19 Mobil Oil Corp. Diamondoid derivatives for pharmaceutical use
US5684024A (en) * 1996-01-25 1997-11-04 Viropharma Incorporated Pyrazole dimers compositions and methods for treating influenza
US5821243A (en) * 1996-07-22 1998-10-13 Viropharma Incorporated Compounds compositions and methods for treating influenza
EP0870757B1 (en) * 1997-04-10 2002-06-12 Pfizer Inc. Fluoro-substituted adamantane derivatives
GB0013737D0 (en) 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
WO2003004461A1 (en) * 2001-07-02 2003-01-16 Schering Corporation Drugs for treating viral infections
SE0103836D0 (en) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
WO2004056744A1 (en) * 2002-12-23 2004-07-08 Janssen Pharmaceutica N.V. Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
SE0300480D0 (en) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
US7338961B2 (en) * 2005-06-17 2008-03-04 Apogee Biotechnology Corporation Sphingosine kinase inhibitors
AR057623A1 (en) 2005-11-28 2007-12-05 Omega Bio Pharma H K Ltd MATERIALS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
ES2388454T3 (en) 2007-03-22 2012-10-15 Astrazeneca Ab Quinoline derivatives for the treatment of inflammatory diseases
PE20091036A1 (en) 2007-11-30 2009-08-15 Astrazeneca Ab QUINOLINE DERIVATIVE AS ANTAGONIST OF THE P2X7 RECEPTOR
US9227990B2 (en) 2012-10-29 2016-01-05 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
WO2015086428A1 (en) * 2013-12-09 2015-06-18 Unilever Plc Process of making adamantanamides
US10583171B2 (en) 2015-11-30 2020-03-10 INSERM (Institut National de la Santé et de la Recherche Médicale) NMDAR antagonists for the treatment of diseases associated with angiogenesis
US11548893B2 (en) 2017-07-15 2023-01-10 Arisan Therapeutics Inc. Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection

Also Published As

Publication number Publication date
CH479535A (en) 1969-10-15
NL6408505A (en) 1965-01-25
ES302369A1 (en) 1965-03-16
SE320363B (en) 1970-02-09
FI42322B (en) 1970-03-31
GB1069563A (en) 1967-05-17
FR1572956A (en) 1969-07-04
DK114769B (en) 1969-08-04
AT279581B (en) 1970-03-10
DE1792295B1 (en) 1971-05-27
FI42548B (en) 1970-06-01
CH476673A (en) 1969-08-15
FI42211B (en) 1970-03-02
BE650919A (en) 1964-11-16
DE1793208A1 (en) 1972-04-06
DE1468769B1 (en) 1972-06-29
IL21753A (en) 1968-01-25
SE330693B (en) 1970-11-30
DE1793207A1 (en) 1972-03-30
NL7102097A (en) 1971-05-25
BR6460975D0 (en) 1973-08-09
DK114199B (en) 1969-06-09
SE321924B (en) 1970-03-23
US3352912A (en) 1967-11-14

Similar Documents

Publication Publication Date Title
DK112027B (en) Process for the preparation of basic tricyclic compounds or their salts, formamides or N-halogenamines.
DK116794B (en) Process for the preparation of biphenyl derivatives or salts thereof.
DK120534B (en) Analogous process for the preparation of benzene sulphonylureas or their salts.
DK109265C (en) Process for the preparation of substituted chlorobenzene-2,4-disulfonamides or salts thereof.
DK108574C (en) Process for the preparation of derivatives of 7-oxy-2-oxo-1,2-dihydrogenquinoline or salts thereof.
DK115111B (en) Process for the preparation of 2-anilinonicotinic acid derivatives or their salts.
DK112520B (en) Process for the preparation of naphthalene compounds or salts thereof.
DK106735C (en) Process for the preparation of benzenesulfonylsemicarbazides or salts thereof.
DK118772B (en) Process for the preparation of aryloxyalkanolamine derivatives or salts thereof.
DK108309C (en) Process for the preparation of 3-sulfanilamido-isoxazoles or salts thereof.
DK114983B (en) Process for the preparation of triarylalkane derivatives or salts thereof.
DK105591C (en) Process for the preparation of 4-carboxyalkylmercapto-5-aryl-pyrimidines or salts thereof.
DK117494B (en) Process for the preparation of 4-aminoantipyride derivatives or salts thereof.
DK108919C (en) Process for the preparation of 1,2-diaryl-4-alkyl-3,5-dioxo-pyrazolidines or salts thereof.
DK107619C (en) Process for the preparation of 2-substituted 5-nitrofurans or salts thereof.
DK106850C (en) Process for the preparation of azepine derivatives or their salts.
DK108365C (en) Process for the preparation of tetrahydrothiapyranylbenzenesulfonylureas or salts thereof.
DK105922C (en) Process for the preparation of pyridyl-2-methylene-aminoguanidines or salts thereof.
DK115262B (en) Process for the preparation of 2-guanidinoalkyl-1-aza-cycloakylimine compounds or salts thereof.
DK109927C (en) Process for the preparation of substituted malonic acid monohydrazides or salts thereof.
DK118823B (en) Process for the preparation of 2-mercaptothiazolyl-benzimidazole compounds or salts thereof.
DK106734C (en) Process for the preparation of emetin or its salts.
DK116283B (en) Process for the preparation of α-aminopenicillins or their salts.
DK106550C (en) Process for the preparation of 3α-hydroxy- or 3α-acyloxy-20β-alkylmethylamino-5β-pregnanes or salts thereof.
DK108625C (en) Process for the preparation of 1-methyl-N-carbobenzoxy-dihydrolysergamine or salts thereof.